Skip to content

A Real-World Registry Study of Compound Duzhong Jiangu Granules in the Treatment of Knee Osteoarthritis (KOA)

A Real-World Registry Study of Compound Duzhong Jiangu Granules in the Treatment of Knee Osteoarthritis (KOA)

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126072
Enrollment
Unknown
Registered
2026-06-03
Start date
2025-02-28
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

use Compound Eucommia ulmoides Jian Gu Granules alone, or in combination with Compound Eucommia ulmoides Jian Gu Granules on the basis of conventional treatment:None
conventional treatment regimen:None

Sponsors

The Third Affiliated Hospital of Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of the Guidelines for the Diagnosis and Treatment of Osteoarthritis of the Knee (2018 Edition); 2. Exposure group: use compound Eucommia ulmoides bone granules; Non-exposed group: no compound Eucommia ulmoides Jiangu granules were used; 3.Age between 50~75 years old, male or female; 4. Those who voluntarily accept the treatment of this protocol, can adhere to the follow-up according to the doctor's instructions and have good compliance, sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with malignant tumors; 2.Patients with a history of liver disease and kidney disease; 3.Those with allergies and allergies to a variety of drugs; 4.patients undergoing total knee arthroplasty; 5.Patients undergoing unicompartmental arthroplasty; 6.Mentally ill patients, glaucoma patients, women who are lactating, pregnant or have recently intended to become pregnant; 7.Those who are in critical condition and it is difficult to make a definitive evaluation of the safety and effectiveness of drugs; 8.Those who are participating in another clinical study.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale for Pain;

Secondary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index;Main Symptoms/Signs and TCM Syndrome Graded Quantitative Scoring Scale;

Countries

China

Contacts

Public ContactWeiHeng Chen

The Third Affiliated Hospital of Beijing University of Chinese Medicine

drchenweiheng@163.com+86 135 1101 3261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026